Computer-aided Discovery of Peptides that Specifically Attack Bacterial Biofilms

Area of Science:

• Microbiology
• Medicinal Chemistry
• Computational Biology

Background:

• Bacterial biofilms exhibit intrinsic resistance to conventional antibiotics, posing a significant clinical challenge.
• Synthetic immunomodulatory cationic peptide 1018 shows broad-spectrum antibiofilm activity, but sequence-activity relationships remain underexplored.

Purpose of the Study:

• To systematically study sequence determinants of antibiofilm peptide activity.
• To develop quantitative structure-activity relationship (QSAR) models for predicting antibiofilm peptide efficacy.
• To identify novel, potent antibiofilm peptides with therapeutic potential.

Main Methods:

• SPOT-synthesis of a 96-variant peptide library based on peptide 1018.
• Evaluation of peptide activity against methicillin-resistant Staphylococcus aureus (MRSA) biofilms.
• Development of 3D QSAR models using molecular descriptors and prediction of virtual peptide sequences.
• In vitro and in vivo validation of identified lead compounds.

Main Results:

• QSAR models achieved approximately 85% prediction accuracy for antibiofilm activity.
• Peptide 3002 demonstrated an 8-fold increase in antibiofilm potency compared to peptide 1018.
• Peptide 3002 significantly reduced abscess size in a chronic MRSA mouse infection model.

Conclusions:

• QSAR modeling is a successful strategy for identifying highly potent antibiofilm peptides.
• The identified peptide 3002 exhibits significant therapeutic potential against antibiotic-resistant bacterial infections.
• This study provides a framework for the rational design of novel antibiofilm agents.